These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24630158)

  • 1. The genetic contribution to recurrent autoimmune nephritis.
    Brenchley PE; Poulton K; Morton M; Picton ML
    Transplant Rev (Orlando); 2014 Jul; 28(3):140-4. PubMed ID: 24630158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
    Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM
    Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase A2 receptor positive membranous nephropathy long after living donor kidney transplantation between identical twins.
    Saito H; Hamasaki Y; Tojo A; Shintani Y; Shimizu A; Nangaku M
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():101-4. PubMed ID: 26031599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathogenesis of membranous nephropathy: evolution and revolution.
    Glassock RJ
    Curr Opin Nephrol Hypertens; 2012 May; 21(3):235-42. PubMed ID: 22388552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membranous Nephropathy (MN) Recurrence After Renal Transplantation.
    Passerini P; Malvica S; Tripodi F; Cerutti R; Messa P
    Front Immunol; 2019; 10():1326. PubMed ID: 31244861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation.
    Gupta G; Fattah H; Ayalon R; Kidd J; Gehr T; Quintana LF; Kimball P; Sadruddin S; Massey HD; Kumar D; King AL; Beck LH
    Clin Transplant; 2016 Apr; 30(4):461-9. PubMed ID: 26854647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients.
    Berchtold L; Letouzé E; Alexander MP; Canaud G; Logt AV; Hamilton P; Mousson C; Vuiblet V; Moyer AM; Guibert S; Mrázová P; Levi C; Dubois V; Cruzado JM; Torres A; Gandhi MJ; Yousfi N; Tesar V; OndrejViklický ; Hourmant M; Moulin B; Rieu P; Choukroun G; Legendre C; Wetzels J; Brenchley P; Ballarín Castan JA; Debiec H; Ronco P
    Kidney Int; 2021 Mar; 99(3):671-685. PubMed ID: 32889013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of membranous nephropathy: a new paradigm in evolution.
    Glassock RJ
    Contrib Nephrol; 2013; 181():131-42. PubMed ID: 23689575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].
    Pozdzik AA; Debiec H; I Brochériou ; Husson C; Rorive S; Broeders N; Le Moine A; Ronco P; Nortier J
    Rev Med Brux; 2015; 36(3):166-71. PubMed ID: 26372979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of membranous nephropathy: update.
    Kwatra IS; Prasher PK
    J Assoc Physicians India; 2013 Nov; 61(11):807-10. PubMed ID: 24974493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent IgA nephropathy in renal transplant allografts.
    Wang AY; Lai FM; Yu AW; Lam PK; Chow KM; Choi PC; Lui SF; Li PK
    Am J Kidney Dis; 2001 Sep; 38(3):588-96. PubMed ID: 11532693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent membranous nephropathy after transplantation: donor antigen and HLA converge in defining risk.
    Robson KJ; Kitching AR
    Kidney Int; 2021 Mar; 99(3):545-548. PubMed ID: 33637201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrence of de novo membranous glomerulonephritis and recurrent IgA nephropathy in a renal allograft.
    Pindur J; Mosheim MB; Giron MA; Guerriero WG; Suki W; Truong L
    Clin Nephrol; 1994 Oct; 42(4):269-72. PubMed ID: 7834922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence from primary and secondary glomerulopathy after renal transplant.
    Canaud G; Audard V; Kofman T; Lang P; Legendre C; Grimbert P
    Transpl Int; 2012 Aug; 25(8):812-24. PubMed ID: 22507183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-phospholipase A2 receptor antibodies and the pathogenesis of membranous nephropathy.
    Ronco P; Debiec H
    Nephron Clin Pract; 2014; 128(3-4):232-7. PubMed ID: 25401774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of glomerulonephritis after renal transplantation.
    Sprangers B; Kuypers DR
    Transplant Rev (Orlando); 2013 Oct; 27(4):126-34. PubMed ID: 23954034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplant recurrence of primary glomerulonephritis.
    Ponticelli C; Glassock RJ
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2363-72. PubMed ID: 21030574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does the primary disease recur in kidney transplantation?].
    Weinreich T; Binswanger U
    Ther Umsch; 1995 Sep; 52(9):566-71. PubMed ID: 7502260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLA2R autoantibodies and recurrent membranous nephropathy after transplantation.
    Stahl R; Hoxha E; Fechner K
    N Engl J Med; 2010 Jul; 363(5):496-8. PubMed ID: 20818871
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antinuclear antibodies in IgA nephropathy, as well as mesangiocapillary and membranous glomerulonephritis].
    Nagy J; Goshen E; Livne A; Sarov I; Shoenfeld Y
    Orv Hetil; 1991 Mar; 132(12):623-8. PubMed ID: 2011384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.